Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies Raises A$258K

NEW YORK (GenomeWeb) – Genetic Technologies said today that its share purchase plan raised A$257,500 (US$211,000). 

The purchase plan closed on Dec. 22 and the company received applications for about 19 million shares. The new shares were issued today, Genetic Technologies said. Proceeds will be used to expand the commercialization of its BrevaGenplus breast cancer test and for general working capital. 

The Melbourne, Australia-based firm is in the midst of a restructuring effort that includes the divestiture of non-core assets in order to focus on its US molecular diagnostics business and the commercialization of the BrevaGenplus test. Last month, Genetic Technologies sold its heritage Australian Genetics business for A$2 million as part of that plan. 

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.